RFA and anti-PD-1 combination therapy suppresses abscopal HCC tumors and prevents recurrence in mice
Peer-Reviewed Publication
This month, we’re focusing on infectious diseases, a topic that affects lives and communities around the world. Here, you’ll find the latest research news, insights, and discoveries shaping how infectious diseases are being studied, prevented, and treated globally.
Updates every hour. Last Updated: 12-Dec-2025 17:11 ET (12-Dec-2025 22:11 GMT/UTC)
New research found that combining radiofrequency ablation (RFA) with anti-PD-1 immunotherapy provides dual therapeutic benefits for hepatocellular carcinoma (HCC), effectively controlling distant tumors while preventing recurrence. The combination therapy significantly enhances infiltration of CD8+ T cells and dendritic cells while reducing PMN-MDSCs, mediated through activation of CXCL10/JAK-STAT signaling pathways. Importantly, this approach establishes durable immune memory capable of inhibiting growth of rechallenge tumor.
Non-invasive respiratory support has transformed the treatment of acute hypoxemic respiratory failure, yet choosing the best option remains challenging. A special issue of the Journal of Intensive Medicine explores currently available strategies and their roles in improving patient outcomes and avoiding intubation. Through both expert reviews and original research, this special issue offers practical, evidence-based guidance to help medical practitioners navigate a critical aspect of intensive care.
A research team has evaluated the real-world effectiveness of a community-based pneumococcal vaccination support program for older adults. They conducted their study in Sera Town, Hiroshima Prefecture, Japan. Their research shows that the pneumococcal vaccination support program for older residents reduced pneumonia-related mortality.